Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Inverness Medical Innovations has completed its stock-for-stock acquisition of diagnostics tools maker Cholestech Corporation.
Subscribe to our email newsletter
Massachusetts-based diagnostics products manufacturer Inverness completed the acquisition through the merger of a wholly-owned subsidiary with and into Cholestech, after Cholestech's shareholders approved the deal.
Ron Zwanziger, chairman, president and CEO of Inverness, said: “The acquisition of Cholestech together with our recent and pending acquisitions, provides Inverness with the unique ability to assess cardiac risk, diagnose cardiac conditions and potentially monitor the condition and response to therapy of cardiac patients.”